Trial intelligence / Profile preview

ASCEND: Sertraline vs CBT in ESRD Depression

NCT02358343Phase 3Completed

Sponsor
University of Washington
Start
Mar 2015
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sertraline in major depressive disorder (MDD), sponsored by University of Washington. Started Mar 2015; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT02358343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02358343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call